What this page helps you do
Use this guide to prepare a Mongolia-based adult hematology case for remote review, clarify any required national cross-border documentation and protect continuity across a long journey.
- Before hospital review
- Ask the treating hematologist to record the diagnosis, current disease status, treatment response, urgency and the exact question for the additional transplant center.
- Documents
- Send dated source reports rather than a summary alone. Keep Mongolian originals and arrange English or Turkish translation only where the reviewing team requests it.
- Travel
- The published visa exemption for Mongolian ordinary passports covers short touristic visits; it does not by itself authorize travel for treatment. Confirm the medical-purpose route, planned stay and any Mongolian transplant-travel documentation before booking.
- Continuity of care
- Because travel to Gebze is long, agree who in Mongolia will manage medicines, blood counts, infection concerns and urgent review after return, and how the discharge record will reach that team.
- Official national statistics describe prior bone-marrow stem-cell transplant activity; they do not confirm current availability, waiting time or eligibility for a particular patient.
- General entry or tourism visa-exemption rules do not themselves authorize travel for treatment. Medical-purpose requirements and the expected stay must be reconfirmed for the individual case.
- No hospital acceptance, donor suitability, treatment date, price or outcome is inferred from national statistics or travel rules.
Travel information checked 11 October 2026. Reconfirm requirements before booking.
Adult BMT Evaluation in Turkey from Mongolia
Adults in Mongolia may request a remote review when a treating hematologist is considering bone marrow or hematopoietic stem-cell transplantation. Review before travel helps identify missing records but does not confirm eligibility or admission.
Care in Mongolia and an International Review Are Separate
Mongolia’s official 2023 health indicators report domestic bone-marrow stem-cell transplantation and describe regulatory certification for Mongolian citizens travelling abroad for transplant treatment. These national data do not establish suitability, capacity or timing for an individual patient, so the treating hematologist and responsible Mongolian authority should confirm the current pathway.
This page does not claim that appropriate hematology care is unavailable in Mongolia. A Turkish hospital review is an additional, case-specific option rather than a conclusion about the national health system.
Anadolu Adult Bone Marrow Transplant Program
Anadolu’s official sources describe a dedicated adult center with inpatient, outpatient, HLA-typing, hemapheresis and stem-cell processing services. Anadolu is the published partner for this campaign, not the only program a patient may consider.
Autologous or Allogeneic Is a Clinical Decision
Autologous or allogeneic transplantation, conditioning intensity, stem-cell source and timing can only be selected after the adult transplant team reviews the diagnosis, disease status, prior treatment, organ function and alternatives.
A preliminary referral must not be interpreted as a recommendation for either type.
Potential Donor Information and HLA Review
A relative or other possible donor is not automatically suitable. Allogeneic transplantation requires hospital-led HLA testing, medical assessment, informed consent and any applicable legal or registry checks.
MedTransplant does not source donors and cannot confirm whether a family member or registry route is available for a particular case.
Preparing Records in Mongolia
Organize the latest information without delaying urgent local care.
- Current hematology summary, diagnosis and reason for another opinion
- Dated pathology, marrow, flow-cytometry, cytogenetic and molecular reports
- Treatment chronology, response, transfusions and complications
- Recent blood counts, infection screening and organ-function assessment
- Available HLA or possible-donor information only when requested
- Treating hematologist’s contact details and a post-return monitoring plan
From Case Review to Specialist Response
MedTransplant checks the file structure, coordinates submission to the appropriate program and communicates requests or a preliminary response. The hospital may request new pathology review, testing or consultation.
Request a Hospital-Program Comparison
Patients may also explore other verified hospital programs or request comparison through MedTransplant. The useful comparison is based on review scope, clinical fit and logistics—not unsupported claims of superiority.
Planning Travel from Mongolia
Travel should normally follow a meaningful hospital response. Clarify who must travel, which tests are required, expected assessment stages and how long the patient may need to remain near the center.
Case-Specific Financial Planning
No unverified price is stated. If the center can progress the case, any quotation may depend on diagnostics, donor evaluation, cell collection, conditioning, admission and the proposed care plan.
Follow-up After Returning to Mongolia
Coordinate with a local hematology team before treatment. Monitoring medicines, infections, blood counts, immune recovery and urgent complications must remain continuous after return.
Continue with the Anadolu Adult BMT Guide
Review the partner-program evaluation pathway, clinical boundaries and records required for a preliminary assessment.
Explore adult BMT evaluation at AnadoluFrequently Asked Questions
Can a case from Mongolia be reviewed before travel?
Available records can be prepared for preliminary specialist review. This does not guarantee acceptance or an in-person appointment.
Is bone marrow transplant the same as stem-cell transplant?
Bone marrow is one possible source of blood-forming stem cells. The appropriate terminology and source depend on the proposed clinical pathway.
Who decides between autologous and allogeneic transplant?
The responsible transplant team decides after reviewing the diagnosis, disease status, prior treatment, health and possible cell sources.
Does a willing relative qualify as a donor?
Not automatically. HLA matching, donor health, consent and applicable legal or registry requirements require separate assessment.
Can MedTransplant find a donor?
No. MedTransplant does not find, recruit, sell, broker or guarantee stem-cell donors.
Does submission guarantee acceptance?
No. Submission guarantees neither hospital acceptance, donor suitability, transplantation, timing nor outcome.
Can I compare Anadolu with another hospital?
Yes. Anadolu is the published partner for this campaign, while patients may explore other verified programs or request a comparison through MedTransplant.
When should travel be booked?
Generally after the hospital has reviewed the available file and described the next possible assessment steps.
Sources and verification
- Anadolu Medical Center: Bone Marrow Transplant Center
- Anadolu Medical Center: Gebze hospital
- Anadolu Medical Center: Hematologic Oncology
- National Cancer Institute: Stem cell transplants in cancer treatment
- National Cancer Institute: Blood stem cell donation
- Mongolia Center for Health Development: Health Indicators 2023
- Mongolia Ministry of Health: Organ, tissue and cell transplantation law
- Türkiye Ministry of Foreign Affairs: Visa information for foreigners
- Türkiye Ministry of Foreign Affairs: General information about Turkish visas
Medical responsibility
MedTransplant coordinates case preparation and referral. It does not provide medical advice, determine eligibility, select a cell source, arrange donors or guarantee acceptance, timing or outcomes.
